GlassScriptPhysician profile
Naji M Hamdan
NPI 1679570873
$1,814.25
in general payments reported to CMS, 2019-2025
19 companies · $698 in 2025
The $698 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2021: $58.59 · 2022: $66.96 · 2023: $315 · 2024: $527 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.00 | 2021-2025 | |
| Pfizer INC. | $219.09 | 2023-2025 | |
| Abiomed | $213.27 | 2022-2024 | Impella |
| Abbott Laboratories | $203.59 | 2023-2024 | Coroflow, Cardiomems |
| Biosense Webster, INC. | $197.68 | 2025 | Carto 3 |
| W. L. Gore & Associates, INC. | $152.05 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Astrazeneca Pharmaceuticals LP | $90.80 | 2019-2023 | Wainua |
| Novo Nordisk INC | $86.56 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $82.41 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $63.63 | 2021-2025 | Cds - Mct/Cem Monitoring |
| Kestra Medical Technology Services, INC. | $42.46 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.08 | 2023-2024 | Lifevest |
| Philips North America LLC | $38.71 | 2023-2024 | (Cm9) Amb Mon & Diag Und |
| Janssen Pharmaceuticals, INC | $28.29 | 2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $21.74 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.37 | 2019 | |
| Preventice Services, LLC | $17.33 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.97 | 2019 | |
| Itamar Medical INC | $15.22 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naji Hamdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.